{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T21:32:39Z","timestamp":1789075959661,"version":"build-2803163510"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No.82203818"],"award-info":[{"award-number":["No.82203818"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 82573305"],"award-info":[{"award-number":["No. 82573305"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hum Genomics"],"DOI":"10.1186\/s40246-025-00850-6","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T04:44:40Z","timestamp":1762922680000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Comprehensive pan-cancer analysis of USP35 and validation of its role in gastric cancer"],"prefix":"10.1186","volume":"19","author":[{"given":"Lirong","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhe","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moye","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,12]]},"reference":[{"key":"850_CR1","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s41467-018-03107-0","volume":"9","author":"J Park","year":"2018","unstructured":"Park J, Kwon M-S, Kim EE, Lee H, Song EJ. USP35 regulates mitotic progression by modulating the stability of Aurora B. Nat Commun. 2018;9:688.","journal-title":"Nat Commun"},{"key":"850_CR2","doi-asserted-by":"publisher","first-page":"C355","DOI":"10.1152\/ajpcell.00733.2024","volume":"328","author":"W Lian","year":"2025","unstructured":"Lian W, Hong C, Chen D, Wang C. USP35 promotes breast cancer progression by regulating PFK-1 ubiquitination to mediate Glycolysis. Am J Physiol Cell Physiol. 2025;328:C355\u201366.","journal-title":"Am J Physiol Cell Physiol"},{"key":"850_CR3","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3892\/ijo.2023.5561","volume":"63","author":"T Lv","year":"2023","unstructured":"Lv T, Zhang B, Jiang C, Zeng Q, Yang J, Zhou Y. USP35 promotes hepatocellular carcinoma progression by protecting PKM2 from ubiquitination\u2013mediated degradation. Int J Oncol. 2023;63:113.","journal-title":"Int J Oncol"},{"key":"850_CR4","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/s42003-025-07513-1","volume":"8","author":"J Cao","year":"2025","unstructured":"Cao J, Wu T, Zhou T, et al. USP35 promotes the growth of ER positive breast cancer by inhibiting ferroptosis via BRD4-SLC7A11 axis. Commun Biol. 2025;8:64.","journal-title":"Commun Biol"},{"key":"850_CR5","doi-asserted-by":"publisher","first-page":"zyae021","DOI":"10.1093\/intbio\/zyae021","volume":"16","author":"Z Zou","year":"2024","unstructured":"Zou Z, Chen S, Wu Y, Ji S. The USP35-CXCR3 axis plays an oncogenic role in JeKo-1 mantle cell lymphoma cells. Integr Biol (Camb). 2024;16:zyae021.","journal-title":"Integr Biol (Camb)"},{"key":"850_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-023-01176-3","author":"S W","year":"2023","unstructured":"Wang S, Wang T, Zhang X, et al. The deubiquitylating enzyme USP35 restricts regulated cell death to promote survival of renal clear cell carcinoma. Cell Death Differ. 2023. https:\/\/doi.org\/10.1038\/s41418-023-01176-3.","journal-title":"Cell Death Differ"},{"key":"850_CR7","doi-asserted-by":"publisher","first-page":"953","DOI":"10.7150\/ijbs.87176","volume":"20","author":"C Ma","year":"2024","unstructured":"Ma C, Tian Z, Wang D, Gao W, Qian L, Zang Y, Xu X, Jia J, Liu Z. Ubiquitin-specific protease 35 promotes gastric cancer metastasis by increasing the stability of Snail1. Int J Biol Sci. 2024;20:953\u201367.","journal-title":"Int J Biol Sci"},{"key":"850_CR8","doi-asserted-by":"crossref","unstructured":"Navarro F, Lozano T, Fuentes-Garc\u00eda A, et al. Reprogramming glutamine metabolism enhances BCMA-CART cell fitness and therapeutic efficacy in multiple myeloma. Blood blood. 2024027496. 2025.","DOI":"10.1182\/blood.2024027496"},{"key":"850_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-025-01582-9","author":"S Chen","year":"2025","unstructured":"Chen S, Lin J, Yang Z, et al. TRIM24-mediated K27-linked ubiquitination of ULK1 alleviates energy stress-induced autophagy and promote prostate cancer growth in the context of SPOP mutation. Cell Death Differ. 2025. https:\/\/doi.org\/10.1038\/s41418-025-01582-9.","journal-title":"Cell Death Differ"},{"key":"850_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1005-x","author":"JL Ae","year":"2019","unstructured":"Lee J, Yesilkanal AE, et al. Effective breast cancer combination therapy targeting BACH1 and mitochondrial metabolism. Nature. 2019. https:\/\/doi.org\/10.1038\/s41586-019-1005-x.","journal-title":"Nature"},{"key":"850_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-019-0658-4","author":"Z Z","year":"2020","unstructured":"Zhang Z, Li TE, Chen M, et al. MFN1-dependent alteration of mitochondrial dynamics drives hepatocellular carcinoma metastasis by glucose metabolic reprogramming. Br J Cancer. 2020. https:\/\/doi.org\/10.1038\/s41416-019-0658-4.","journal-title":"Br J Cancer"},{"key":"850_CR12","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1126\/science.123.3191.309","volume":"123","author":"O Warburg","year":"1956","unstructured":"Warburg O. On the origin of cancer cells. Science. 1956;123:309\u201314.","journal-title":"Science"},{"key":"850_CR13","doi-asserted-by":"publisher","DOI":"10.1113\/JP280572","author":"K Sj","year":"2021","unstructured":"Kierans SJ, Taylor CT. Regulation of Glycolysis by the hypoxia-inducible factor (HIF): implications for cellular physiology. J Physiol. 2021. https:\/\/doi.org\/10.1113\/JP280572.","journal-title":"J Physiol"},{"key":"850_CR14","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.1111\/jcmm.13572","volume":"22","author":"Y Wang","year":"2018","unstructured":"Wang Y, Han X, Fu M, Wang J, Song Y, Liu Y, Zhang J, Zhou J, Ge J. Qiliqiangxin attenuates hypoxia-induced injury in primary rat cardiac microvascular endothelial cells via promoting HIF-1\u03b1-dependent Glycolysis. J Cell Mol Med. 2018;22:2791\u2013803.","journal-title":"J Cell Mol Med"},{"key":"850_CR15","doi-asserted-by":"publisher","first-page":"e22326","DOI":"10.1096\/fj.202101742RR","volume":"36","author":"R Li","year":"2022","unstructured":"Li R, Wu X, Zhao P, Xue K, Li J. A pan-cancer analysis identifies HDAC11 as an immunological and prognostic biomarker. FASEB J. 2022;36:e22326.","journal-title":"FASEB J"},{"key":"850_CR16","doi-asserted-by":"publisher","first-page":"e23159","DOI":"10.1096\/fj.202300626R","volume":"37","author":"X Gao","year":"2023","unstructured":"Gao X, Bu H, Gao X, Wang Y, Wang L, Zhang Z. Pan-cancer analysis: SPAG5 is an immunological and prognostic biomarker for multiple cancers. FASEB J. 2023;37:e23159.","journal-title":"FASEB J"},{"key":"850_CR17","doi-asserted-by":"publisher","first-page":"15647","DOI":"10.3390\/ijms232415647","volume":"23","author":"J Xie","year":"2022","unstructured":"Xie J, Zhang J, Tian W, et al. The Pan-Cancer Multi-Omics landscape of FOXO family relevant to clinical outcome and drug resistance. Int J Mol Sci. 2022;23:15647.","journal-title":"Int J Mol Sci"},{"key":"850_CR18","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.1002\/imt2.36","volume":"1","author":"W Shen","year":"2022","unstructured":"Shen W, Song Z, Zhong X, et al. Sangerbox: A comprehensive, interaction-friendly clinical bioinformatics analysis platform. iMeta. 2022;1:e36.","journal-title":"iMeta"},{"key":"850_CR19","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s40537-023-00844-y","volume":"10","author":"Z Liu","year":"2023","unstructured":"Liu Z, Liu L, Weng S, et al. BEST: a web application for comprehensive biomarker exploration on large-scale data in solid tumors. J Big Data. 2023;10:165.","journal-title":"J Big Data"},{"key":"850_CR20","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","volume":"77","author":"T Li","year":"2017","unstructured":"Li T, Fan J, Wang B, Traugh N, Chen Q, Liu JS, Li B, Liu XS. TIMER: A web server for comprehensive analysis of Tumor-Infiltrating immune cells. Cancer Res. 2017;77:e108\u201310.","journal-title":"Cancer Res"},{"key":"850_CR21","doi-asserted-by":"publisher","first-page":"e71880","DOI":"10.7554\/eLife.71880","volume":"11","author":"C Yang","year":"2022","unstructured":"Yang C, Zhang H, Chen M, et al. A survey of optimal strategy for signature-based drug repositioning and an application to liver cancer. Elife. 2022;11:e71880.","journal-title":"Elife"},{"key":"850_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2018.03.034","author":"T M","year":"2018","unstructured":"Malta TM, Sokolov A, Gentles AJ, et al. Machine learning identifies stemness features associated with oncogenic dedifferentiation. Cell. 2018. https:\/\/doi.org\/10.1016\/j.cell.2018.03.034.","journal-title":"Cell"},{"key":"850_CR23","doi-asserted-by":"publisher","first-page":"e390","DOI":"10.1002\/ctm2.390","volume":"11","author":"Z Tang","year":"2021","unstructured":"Tang Z, Jiang W, Mao M, Zhao J, Chen J, Cheng N. Deubiquitinase USP35 modulates ferroptosis in lung cancer via targeting Ferroportin. Clin Transl Med. 2021;11:e390.","journal-title":"Clin Transl Med"},{"key":"850_CR24","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41418-020-0588-y","volume":"28","author":"J Zhang","year":"2021","unstructured":"Zhang J, Chen Y, Chen X, et al. Deubiquitinase USP35 restrains STING-mediated interferon signaling in ovarian cancer. Cell Death Differ. 2021;28:139\u201355.","journal-title":"Cell Death Differ"},{"key":"850_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41374-021-00725-z","author":"C L","year":"2022","unstructured":"Liu C, Chen Z, Ding X, Qiao Y, Li B. Ubiquitin-specific protease 35 (USP35) mediates cisplatin-induced apoptosis by stabilizing BIRC3 in non-small cell lung cancer. Lab Invest. 2022. https:\/\/doi.org\/10.1038\/s41374-021-00725-z.","journal-title":"Lab Invest"},{"key":"850_CR26","doi-asserted-by":"publisher","first-page":"27891","DOI":"10.18632\/oncotarget.4451","volume":"6","author":"C Liu","year":"2015","unstructured":"Liu C, Wang L, Chen W, Zhao S, Yin C, Lin Y, Jiang A, Zhang P. USP35 activated by MiR let-7a inhibits cell proliferation and NF-\u03baB activation through stabilization of ABIN-2. Oncotarget. 2015;6:27891\u2013906.","journal-title":"Oncotarget"},{"key":"850_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/1878-0261.13112","author":"W W","year":"2022","unstructured":"Wang W, Wang M, Xiao Y, Wang Y, Ma L, Guo L, Wu X, Lin X, Zhang P. USP35 mitigates Endoplasmic reticulum stress-induced apoptosis by stabilizing RRBP1 in non-small cell lung cancer. Mol Oncol. 2022. https:\/\/doi.org\/10.1002\/1878-0261.13112.","journal-title":"Mol Oncol"},{"key":"850_CR28","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/s41419-021-03904-4","volume":"12","author":"J Cao","year":"2021","unstructured":"Cao J, Wu D, Wu G, et al. USP35, regulated by Estrogen and AKT, promotes breast tumorigenesis by stabilizing and enhancing transcriptional activity of Estrogen receptor \u03b1. Cell Death Dis. 2021;12:619.","journal-title":"Cell Death Dis"},{"key":"850_CR29","doi-asserted-by":"publisher","first-page":"6124","DOI":"10.3390\/ijms16036124","volume":"16","author":"M Shimizu","year":"2015","unstructured":"Shimizu M, Shirakami Y, Sakai H, Kubota M, Kochi T, Ideta T, Miyazaki T, Moriwaki H. Chemopreventive potential of green tea catechins in hepatocellular carcinoma. Int J Mol Sci. 2015;16:6124\u201339.","journal-title":"Int J Mol Sci"},{"key":"850_CR30","doi-asserted-by":"publisher","first-page":"513","DOI":"10.2165\/00003495-200363050-00005","volume":"63","author":"KF Croom","year":"2003","unstructured":"Croom KF, Perry CM. Imatinib mesylate: in the treatment of Gastrointestinal stromal tumours. Drugs. 2003;63:513\u201322. discussion 523\u2013524.","journal-title":"Drugs"},{"key":"850_CR31","doi-asserted-by":"publisher","first-page":"787","DOI":"10.2217\/14796694.1.6.787","volume":"1","author":"N Reguart","year":"2005","unstructured":"Reguart N, He B, Taron M, You L, Jablons DM, Rosell R. The role of Wnt signaling in cancer and stem cells. Future Oncol. 2005;1:787\u201397.","journal-title":"Future Oncol"},{"key":"850_CR32","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2174\/157489210789702208","volume":"5","author":"SE Ghayad","year":"2010","unstructured":"Ghayad SE, Cohen PA. Inhibitors of the PI3K\/Akt\/mTOR pathway: new hope for breast cancer patients. Recent Pat Anticancer Drug Discov. 2010;5:29\u201357.","journal-title":"Recent Pat Anticancer Drug Discov"},{"key":"850_CR33","doi-asserted-by":"publisher","unstructured":"Sarris EG, Saif MW, Syrigos KN. The biological role of PI3K pathway in lung cancer. Pharmaceuticals. 2012. https:\/\/doi.org\/10.3390\/ph5111236","DOI":"10.3390\/ph5111236"},{"key":"850_CR34","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1097\/JTO.0b013e3181a1084f","volume":"4","author":"OCJ Schuurbiers","year":"2009","unstructured":"Schuurbiers OCJ, Kaanders JHAM, van der Heijden HFM, Dekhuijzen RPN, Oyen WJG, Bussink J. The PI3-K\/AKT-pathway and radiation resistance mechanisms in non-small cell lung cancer. J Thorac Oncol. 2009;4:761\u20137.","journal-title":"J Thorac Oncol"},{"key":"850_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-019-1130-2","author":"LD Lj","year":"2019","unstructured":"Di L, Liu LJ, Yan YM, Fu R, Li Y, Xu Y, Cheng YX, Wu ZQ. Discovery of a natural small-molecule compound that suppresses tumor EMT, stemness and metastasis by inhibiting TGF\u03b2\/BMP signaling in triple-negative breast cancer. J Experimental Clin Cancer Research: CR. 2019. https:\/\/doi.org\/10.1186\/s13046-019-1130-2.","journal-title":"J Experimental Clin Cancer Research: CR"},{"key":"850_CR36","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s10549-019-05166-3","volume":"175","author":"J Lee","year":"2019","unstructured":"Lee J, Lim B, Pearson T, Choi K, Fuson JA, Bartholomeusz C, Paradiso LJ, Myers T, Tripathy D, Ueno NT. Anti-tumor and anti-metastasis efficacy of E6201, a MEK1 inhibitor, in preclinical models of triple-negative breast cancer. Breast Cancer Res Treat. 2019;175:339\u201351.","journal-title":"Breast Cancer Res Treat"},{"key":"850_CR37","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s11427-016-0368-y","volume":"60","author":"X Ying","year":"2017","unstructured":"Ying X, Huang A, Xing Y, Lan L, Yi Z, He P. Lycorine inhibits breast cancer growth and metastasis via inducing apoptosis and blocking Src\/FAK-involved pathway. Sci China Life Sci. 2017;60:417\u201328.","journal-title":"Sci China Life Sci"},{"key":"850_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/med.21771","author":"L Y","year":"2021","unstructured":"You L, Wu W, Wang X, Fang L, Adam V, Nepovimova E, Wu Q, Kuca K. The role of hypoxia-inducible factor 1 in tumor immune evasion. Med Res Rev. 2021. https:\/\/doi.org\/10.1002\/med.21771.","journal-title":"Med Res Rev"},{"key":"850_CR39","doi-asserted-by":"publisher","first-page":"7465","DOI":"10.1158\/0008-5472.CAN-10-1439","volume":"70","author":"AL Doedens","year":"2010","unstructured":"Doedens AL, Stockmann C, Rubinstein MP, Liao D, Zhang N, DeNardo DG, Coussens LM, Karin M, Goldrath AW, Johnson RS. Macrophage expression of hypoxia-inducible factor-1 alpha suppresses T-cell function and promotes tumor progression. Cancer Res. 2010;70:7465\u201375.","journal-title":"Cancer Res"},{"key":"850_CR40","doi-asserted-by":"publisher","first-page":"154676","DOI":"10.1016\/j.prp.2023.154676","volume":"248","author":"S Mirzaei","year":"2023","unstructured":"Mirzaei S, Ranjbar B, Tackallou SH, Aref AR. Hypoxia inducible factor-1\u03b1 (HIF-1\u03b1) in breast cancer: the crosstalk with oncogenic and onco-suppressor factors in regulation of cancer hallmarks. Pathol Res Pract. 2023;248:154676.","journal-title":"Pathol Res Pract"},{"key":"850_CR41","doi-asserted-by":"publisher","first-page":"3689","DOI":"10.1172\/JCI84430","volume":"126","author":"D Triner","year":"2016","unstructured":"Triner D, Shah YM. Hypoxia-inducible factors: a central link between inflammation and cancer. J Clin Invest. 2016;126:3689\u201398.","journal-title":"J Clin Invest"},{"key":"850_CR42","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/s41419-025-07411-8","volume":"16","author":"H Zhang","year":"2025","unstructured":"Zhang H, Zhu J, He R, et al. Deubiquitination enzyme USP35 negatively regulates MAVS signaling to inhibit anti-tumor immunity. Cell Death Dis. 2025;16:138.","journal-title":"Cell Death Dis"},{"key":"850_CR43","doi-asserted-by":"publisher","first-page":"3700","DOI":"10.3390\/cells11223700","volume":"11","author":"AN Clements","year":"2022","unstructured":"Clements AN, Warfel NA. Targeting PIM kinases to improve the efficacy of immunotherapy. Cells. 2022;11:3700.","journal-title":"Cells"},{"key":"850_CR44","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1038\/s41467-025-57465-7","volume":"16","author":"J Song","year":"2025","unstructured":"Song J, Wei R, Liu C, Zhao Z, Liu X, Wang Y, Liu F, Liu X. Antigen-presenting cancer associated fibroblasts enhance antitumor immunity and predict immunotherapy response. Nat Commun. 2025;16:2175.","journal-title":"Nat Commun"},{"key":"850_CR45","doi-asserted-by":"publisher","first-page":"137824","DOI":"10.1016\/j.jhazmat.2025.137824","volume":"490","author":"S Xu","year":"2025","unstructured":"Xu S, Yuan X, Wang Y, Fu Z, Chen K, Cui Z, Xu L, Zhang H, Xia D, Wu Y. Bisphenols exposure at environmentally relevant dose promoted ovarian cancer progression and modulated tumor microenvironment through \u03b2-catenin\/SPP1 axis. J Hazard Mater. 2025;490:137824.","journal-title":"J Hazard Mater"},{"key":"850_CR46","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-24-0131","author":"A Ben-Shmuel","year":"2025","unstructured":"Ben-Shmuel A, Gruper Y, Halperin C, et al. Cancer-associated fibroblasts serve as decoys to suppress NK cell anti-cancer cytotoxicity in breast cancer. Cancer Discov. 2025. https:\/\/doi.org\/10.1158\/2159-8290.CD-24-0131.","journal-title":"Cancer Discov"},{"key":"850_CR47","doi-asserted-by":"crossref","unstructured":"Zhang Y-P, Guo Z-Q, Cai X-T, et al. PAI-1-driven SFRP2high cancer-associated fibroblasts hijack the abscopal effect of radioimmunotherapy. Cancer Cell. 2025;S1535-6108(25)00076\u20135.","DOI":"10.1016\/j.ccell.2025.02.024"},{"key":"850_CR48","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12951-025-03217-0","volume":"23","author":"T Liao","year":"2025","unstructured":"Liao T, Chen X, Qiu F, et al. Regulation of cancer-associated fibroblasts for enhanced cancer immunotherapy using advanced functional nanomedicines: an updated review. J Nanobiotechnol. 2025;23:166.","journal-title":"J Nanobiotechnol"},{"key":"850_CR49","doi-asserted-by":"publisher","first-page":"113606","DOI":"10.1016\/j.jconrel.2025.113606","volume":"381","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Zhou J, Wang Y, Wu Y, Li Y, Wang B, Liu G, Gong Q, Luo K, Jing J. Stimuli-responsive polymer-dasatinib prodrug to reprogram cancer-associated fibroblasts for boosted immunotherapy. J Control Release. 2025;381:113606.","journal-title":"J Control Release"},{"key":"850_CR50","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.1038\/s41598-025-86580-0","volume":"15","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Lv P, Zhang Q, Xiang W, Jiang X, Guo Z, Zhang T. Exosomal miR-21-5p from glioma associated mesenchymal stem cells promotes the progression and Glycolysis of glioblastoma via PDHA1. Sci Rep. 2025;15:2320.","journal-title":"Sci Rep"},{"key":"850_CR51","doi-asserted-by":"crossref","unstructured":"Gore M, Kabekkodu SP, Chakrabarty S. Exploring the metabolic alterations in cervical cancer induced by HPV oncoproteins: from mechanisms to therapeutic targets. Biochim Biophys Acta Rev Cancer. 2025;189292.","DOI":"10.1016\/j.bbcan.2025.189292"},{"key":"850_CR52","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2023.5561","author":"TL B Z","year":"2023","unstructured":"Lv T, Zhang B, Jiang C, Zeng Q, Yang J, Zhou Y. USP35 promotes hepatocellular carcinoma progression by protecting PKM2 from ubiquitination\u2013mediated degradation. Int J Oncol. 2023. https:\/\/doi.org\/10.3892\/ijo.2023.5561.","journal-title":"Int J Oncol"}],"container-title":["Human Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40246-025-00850-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40246-025-00850-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40246-025-00850-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T04:44:42Z","timestamp":1762922682000},"score":1,"resource":{"primary":{"URL":"https:\/\/humgenomics.biomedcentral.com\/articles\/10.1186\/s40246-025-00850-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,12]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["850"],"URL":"https:\/\/doi.org\/10.1186\/s40246-025-00850-6","relation":{},"ISSN":["1479-7364"],"issn-type":[{"value":"1479-7364","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,12]]},"assertion":[{"value":"12 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"134"}}